Dr. Emmy Ludwig, MD

Dr. Ludwig practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Ludwig's NPI, 1386750842, was assigned on August 21, 2006. Dr. Ludwig graduated from Vagelos College of Physicians and Surgeons in 2000. Dr. Ludwig holds New York license 221795.

Dr. Ludwig's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Ludwig's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Ludwig to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ludwig practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ludwig's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ludwig is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ludwig's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists acid reflux, colonoscopy, esophagus, stomach, or upper small intestine surgery, fatty liver, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis and irritable bowel syndrome (IBS) among the conditions Dr. Ludwig treats.

CMS data shows 421 Medicare services from Dr. Ludwig across 11 procedure codes in 2024, for 357 Medicare patients. Medicare paid $49,914 for them.

CMS counts 357 Medicare patients who saw Dr. Ludwig in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ludwig's median patient age at 70, with 59% women.

In 2024, Dr. Ludwig wrote 276 Medicare Part D claims for 100 patients. 82% of them were for generic drugs. CMS names the drug for 188 of them, across 5 drugs with 11 or more claims each, at $9,279 in total drug cost. In 2023, CMS named 209 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Ludwig for performance year 2024, reported as part of a group. Dr. Ludwig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ludwig as offering telehealth. CMS counts 145 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ludwig, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Ludwig, published from 2011 to 2024. 2017 was the busiest year, with 4. The most frequent topics are Pancreatic Neoplasms, Adenocarcinoma and Endoscopy, Gastrointestinal. Dr. Ludwig has published most often in Ann Thorac Surg. Dr. Ludwig's most frequent co-authors are Hans Gerdes, MD, Arnold J. Markowitz, MD and Mark A. Schattner, MD.

CMS Open Payments shows 1 general payment to Dr. Ludwig from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $20.

Dr. Ludwig graduated from Vagelos College of Physicians and Surgeons in 2000.

Dr. Ludwig is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.